Latest diabetic neuropathy Stories
RICHMOND, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today reported fourth quarter and full year 2009 financial results and accomplishments and provided an outlook for 2010.
RICHMOND, Calif., Jan. 11 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.
RICHMOND, Calif., Dec. 9 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.
WALTHAM, Mass., Nov.
Neurologists will use funds to move lab findings into human therapy for difficult-to-treat condition that involves pain from nerve damage ANN ARBOR, Mich., Nov.
SAN MATEO, Calif., Oct. 30 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced it will hold a conference call on Friday, November 6, 2009 at 9:00 a.m. ET (6:00 a.m.
HealthCore study shows Metanx also reduces health plan costs.
RICHMOND, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.
People who suffer from debilitating neuropathic pain may get more relief and sleep better by combining two commonly-prescribed drugs.